Update on noninvasive prenatal testing: A review based on current worldwide research

Area of Science:

• Genetics
• Prenatal Diagnostics
• Molecular Biology

Background:

• Noninvasive prenatal testing (NIPT) has been clinically evaluated for eight years, with data supporting its superior accuracy over conventional first-trimester screening for trisomies 21, 18, and 13.
• Despite widespread global adoption as a clinical screening method, NIPT's utility for detecting sex chromosome aneuploidies and whole-genome regions remains under-researched.
• NIPT is an unconfirmed diagnostic test, necessitating careful interpretation of results due to the possibility of false negatives, false positives, and inconclusive outcomes.

Purpose of the Study:

• To review the current information on NIPT methodologies, limitations, and implications following its worldwide clinical adoption.
• To highlight the need for further research into NIPT's effectiveness for a broader range of genetic abnormalities.
• To emphasize the importance of integrating genetic counseling into NIPT implementation.

Main Methods:

• Literature review of existing data on NIPT accuracy and clinical application.
• Analysis of NIPT methodologies and their associated shortcomings.
• Evaluation of the implications of NIPT results in clinical practice.

Main Results:

• NIPT demonstrates higher accuracy than traditional screening for trisomy 21, 18, and 13.
• Insufficient data exists regarding NIPT's performance for sex chromosome aneuploidies and other genetic variations.
• NIPT results require cautious interpretation due to potential for false positives/negatives and inconclusive findings.

Conclusions:

• NIPT is a valuable screening tool but not a definitive diagnostic test.
• Further research is needed to expand NIPT's application and refine interpretation guidelines.
• Genetic counseling is crucial for informed decision-making and effective utilization of NIPT.